NORRISTOWN, PA — MRO has acquired Clinetic, a fast-growing recruitment management platform that uses artificial intelligence to help hospitals and life sciences companies identify, screen and enroll clinical trial participants more efficiently. The deal positions MRO to expand its role as a centralized data and technology provider in a research landscape where patient recruitment remains one of the industry’s biggest bottlenecks.
MRO said Clinetic’s software and analytics will strengthen its efforts to deliver a single-source, data-driven infrastructure for clinical research. Clinetic installs secure, behind-the-firewall connectors that integrate directly with hospital electronic health record systems, giving research teams access to real-time clinical and historical data needed to build accurate cohorts for complex trial protocols.
Lidia Bernik, president of Curation Solutions at MRO, said hospitals often struggle to participate in clinical studies because they lack the staff, tools or expertise needed to manage recruitment. She said adding Clinetic allows MRO to deliver a scalable “human-in-the-loop” model that supports both providers and trial sponsors.
Clinetic currently evaluates data from more than 15 million patients nationwide. CEO Tom Kaminski said the company’s integration with MRO aligns with its mission to convert unstructured clinical information into actionable insights and expand research access across communities.
MRO plans to deploy Clinetic’s platform across its service lines, including support for hospitals and health systems seeking to increase their engagement in clinical studies. The capabilities will also extend to the Q-Centrix Research Network, a member of the MRO family.
The companies said the initiative is designed to accelerate patient identification, streamline enrollment workflows and improve data quality — all long-standing challenges that slow trial timelines and raise costs. By connecting providers and life sciences organizations through a unified data infrastructure, MRO aims to reduce friction in the trial startup process and strengthen sponsor access to diverse patient populations.
Bernik said the integration signals a broader shift in how research operations are managed. By reducing manual tasks tied to finding and enrolling trial participants, she said research staff can refocus on activities that directly support study progress and patient outcomes.
The acquisition marks another step in MRO’s effort to position itself as a leader in AI-enabled clinical data operations, as demand grows for faster, more precise research capabilities across the healthcare sector.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.